Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 477 Jan 1 – Oct 25, 2026
- Disclosed funding
- $20.2B 403 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| M MindImmuneCompany profile Develops immune-focused therapies for neurodegenerative diseases, including Alzheimer’s disease Develops immune-focused therapies for neurodegenerative diseases, including Alzheimer’s disease | $5M | StrategicUndisclosed | Biotech | United States | Investors | |
| C CytotraitCompany profile Develops crop engineering technology for precise gene editing in plant organelles Develops crop engineering technology for precise gene editing in plant organelles | £3M | Seed | Biotech, Agritech | United Kingdom | Investors | |
| SC Science CorporationCompany profile Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases | $230M | Series CSeries C+ | Biotech, Healthtech | United States | Investors | |
| CS Cellbox SolutionsCompany profile Cellbox Solutions provides portable incubators and warm-chain logistics services for transporting living biological materials. Cellbox Solutions provides portable incubators and warm-chain logistics services for transporting living biological materials. | €5M | Series A — €5m final close October 2026Series A | Biotech | Germany | Investors | |
| N NexCureCompany profile Provides CAR-T and other advanced treatment delivery in community outpatient settings Provides CAR-T and other advanced treatment delivery in community outpatient settings | $19M | Series A | Biotech, Healthtech | United States | Investors | |
AntheiaCompany profile Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. | $9M | BioMaP project agreement expansionUndisclosed | Biotech | United States | Investors Undisclosed | |
Alithea GenomicsCompany profile Alithea Genomics supplies RNA-sequencing preparation kits and services for laboratories running large gene-expression and drug-screening studies. Alithea Genomics supplies RNA-sequencing preparation kits and services for laboratories running large gene-expression and drug-screening studies. | CHF 3M | Seed | Biotech | Switzerland | Investors | |
| S ShellworksCompany profile Develops bio-based plastic alternative materials for packaging and consumer goods Develops bio-based plastic alternative materials for packaging and consumer goods | $15M | Series A | Biotech, Climate tech | United Kingdom | Investors | |
| M MycoverseCompany profile Developing fungal-based biological crop protection solutions using AI-driven discovery platform Developing fungal-based biological crop protection solutions using AI-driven discovery platform | €2.4M | Pre-SeedPre-seed | Biotech, Agritech | Denmark | Investors | |
| PT Poplar TherapeuticsCompany profile Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions | $45M | Series A+Series A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
23rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.